
Sharon Zackfia
Stock Analyst at William Blair
(2.64)
# 2,899
Out of 5,076 analysts
606
Total ratings
41.1%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Sharon Zackfia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCL Royal Caribbean Cruises | Reiterated: Buy | n/a | $276.48 | - | 32 | Oct 20, 2026 | |
| EWTX Edgewise Therapeutics | Initiated Coverage: Buy | $53 | $39.31 | +34.83% | 1 | Oct 15, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $66 | $17.08 | +286.42% | 1 | Oct 15, 2026 | |
| IDYA IDEAYA Biosciences | Initiated Coverage: Buy | $51 | $34.71 | +46.93% | 1 | Oct 15, 2026 | |
| IMNM Immunome | Initiated Coverage: Buy | $35 | $17.99 | +94.55% | 1 | Oct 15, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $38 | $12.80 | +196.88% | 1 | Oct 15, 2026 | |
| PVLA Palvella Therapeutics | Initiated Coverage: Buy | $266 | $125.10 | +112.63% | 1 | Oct 15, 2026 | |
| RVMD Revolution Medicines | Initiated Coverage: Buy | $226 | $186.99 | +20.86% | 1 | Oct 15, 2026 | |
| RYTM Rhythm Pharmaceuticals | Initiated Coverage: Buy | $206 | $89.27 | +130.76% | 1 | Oct 15, 2026 | |
| TNGX Tango Therapeutics | Initiated Coverage: Buy | $42 | $23.34 | +79.95% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.37 | $3.18 | +163.21% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $51.55 | - | 31 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.11 | - | 36 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $100.80 | - | 30 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $31.44 | - | 16 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.81 | - | 7 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.96 | - | 29 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.76 | - | 3 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $99.01 | - | 44 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.57 | - | 21 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.48 | - | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $57.81 | - | 34 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.42 | - | 15 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.82 | - | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.49 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $52.52 | - | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.21 | - | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $65.16 | - | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.52 | - | 38 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.51 | - | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $108.37 | - | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.86 | - | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $119.54 | - | 10 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.67 | n/a | 10 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.74 | n/a | 4 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.000001 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.20 | n/a | 3 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.05 | n/a | 3 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.4836 | n/a | 1 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.79 | n/a | 10 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.11 | n/a | 16 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.84 | n/a | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.30 | n/a | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.64 | n/a | 1 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $85.27 | n/a | 1 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.14 | n/a | 8 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.29 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.56 | n/a | 12 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $28.96 | n/a | 13 | Apr 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 7 | Oct 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.90 | n/a | 1 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $173.44 | n/a | 1 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.16 | n/a | 3 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $86.55 | n/a | 7 | Aug 17, 2015 |
Royal Caribbean Cruises
Oct 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $276.48
Upside: -
Edgewise Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $53
Current: $39.31
Upside: +34.83%
Faeth Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $66
Current: $17.08
Upside: +286.42%
IDEAYA Biosciences
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $34.71
Upside: +46.93%
Immunome
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $17.99
Upside: +94.55%
Kardigan
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $12.80
Upside: +196.88%
Palvella Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $266
Current: $125.10
Upside: +112.63%
Revolution Medicines
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $226
Current: $186.99
Upside: +20.86%
Rhythm Pharmaceuticals
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $206
Current: $89.27
Upside: +130.76%
Tango Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $23.34
Upside: +79.95%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $8.37
Current: $3.18
Upside: +163.21%
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $51.55
Upside: -
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.11
Upside: -
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $100.80
Upside: -
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.44
Upside: -
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.81
Upside: -
Sep 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.96
Upside: -
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.76
Upside: -
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $99.01
Upside: -
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.57
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $53.48
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $57.81
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.42
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $9.82
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $41.49
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $52.52
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.21
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $65.16
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.52
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $56.51
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $108.37
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.86
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $119.54
Upside: -
Aug 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.67
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: n/a
Current: $11.74
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $9.20
Upside: n/a
Jun 14, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $2.05
Upside: n/a
Jan 10, 2023
Reiterated: Buy
Price Target: n/a
Current: $0.4836
Upside: n/a
Sep 26, 2022
Reiterated: Buy
Price Target: n/a
Current: $42.79
Upside: n/a
Sep 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $14.11
Upside: n/a
Aug 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $46.84
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: n/a
Current: $11.30
Upside: n/a
Apr 29, 2022
Reiterated: Buy
Price Target: n/a
Current: $18.64
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: n/a
Current: $85.27
Upside: n/a
Mar 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.14
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $2.29
Upside: n/a
Jul 22, 2020
Reiterated: Hold
Price Target: n/a
Current: $4.56
Upside: n/a
Apr 23, 2020
Reiterated: Hold
Price Target: n/a
Current: $28.96
Upside: n/a
Oct 24, 2018
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: n/a
Current: $2.90
Upside: n/a
Nov 6, 2017
Reiterated: Buy
Price Target: n/a
Current: $173.44
Upside: n/a
Dec 9, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.16
Upside: n/a
Aug 17, 2015
Reiterated: Buy
Price Target: n/a
Current: $86.55
Upside: n/a